Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 3:35 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 27 matching trials from the live ClinicalTrials.gov search.

Filters: Sponsor: The Medical Research Network Clear all

Conditions: Traumatic Brain Injury
Interventions: rTMS, HD-tDCS, Attention Process Training; Device · Other
Lead sponsor: University of New Mexico; Other
Eligibility: 18 Years to 59 Years
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 5
States / cities: Minneapolis, Minnesota • Albuquerque, New Mexico

Conditions: Surgical Procedures, Operative
Interventions: Dexmedetomidine, Remifentanil, Bupivacaine, Ropivacaine; Drug
Lead sponsor: Murdoch Childrens Research Institute; Other
Eligibility: 1 Month to 12 Months
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 4
States / cities: Cincinnati, Ohio • Portland, Oregon • Dallas, Texas + 1 more

Conditions: Social Anxiety Disorder, Major Depressive Disorder
Interventions: Vortioxetine, Placebo; Drug
Lead sponsor: The Medical Research Network; Other
Eligibility: 18 Years to 70 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: ADHD
Interventions: Vayarin, Placebo; Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years to 60 Years
Enrollment: 107 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: New York, New York

Conditions: Social Anxiety Disorder
Interventions: Cariprazine, Placebo; Drug
Lead sponsor: The Medical Research Network; Other
Eligibility: 18 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Anesthesia, Neurotoxicity, Child Development
Interventions: Sevoflurane, Remifentanil, Dexmedetomidine; Drug
Lead sponsor: Murdoch Childrens Research Institute; Other
Eligibility: Up to 2 Years
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2026
U.S. locations: 5
States / cities: Boston, Massachusetts • Cleveland, Ohio • Philadelphia, Pennsylvania + 2 more

Conditions: Bipolar II Disorder, Major Depressive Episode
Interventions: Ziprasidone; Drug
Lead sponsor: The Medical Research Network; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 2
States / cities: New York, New York • Plano, Texas

Conditions: Idiopathic Membranous Nephropathy
Interventions: Rituximab, Cyclosporine; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 80 Years
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 18
States / cities: Birmingham, Alabama • Scottsdale, Arizona • Tucson, Arizona + 13 more

Conditions: Chronic Pancreatitis, Acute Recurrent Pancreatitis
Interventions: Web-based CBT, Pain Education; Behavioral
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 10 Years to 19 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Cardiac Arrest
Interventions: Echocardiography, Electrocardiogram (ECG); Diagnostic Test
Lead sponsor: Romolo Gaspari; Other
Eligibility: 18 Years and older
Enrollment: 813 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 6
States / cities: Hartford, Connecticut • Lebanon, New Hampshire • Stony Brook, New York + 3 more

Conditions: Diabetic Nephropathies, Kidney Failure, Chronic, Diabetes Mellitus Type 1, Heart Failure
Interventions: Sotagliflozin, Placebo; Drug
Lead sponsor: Alessandro Doria; Other
Eligibility: 18 Years to 75 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 13
States / cities: Stanford, California • Aurora, Colorado • Orlando, Florida + 10 more

Conditions: Prostate Cancer
Interventions: No intervention; Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older · Male only
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2022
U.S. locations: 5
States / cities: Baltimore, Maryland • New York, New York • Durham, North Carolina + 2 more

Conditions: Social Anxiety Disorder
Interventions: Vilazodone, Placebo; Drug
Lead sponsor: The Medical Research Network; Other
Eligibility: 18 Years to 75 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Intracerebral Hemorrhage
Interventions: Statins; Drug
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 50 Years and older
Enrollment: 1,456 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Oncology, Breast Cancer, Prostate Cancer, Gynecologic Cancer, Brain Tumor, Brain Cancer, Gynecologic Tumor, Prostate Tumor, Prostate Neoplasm, Breast Tumor, Radiation Toxicity, Quality of Life, Rectal Cancer, Rectal Tumor, Rectal Neoplasms, Lung Cancer, Lung Tumor, Lung Neoplasm, Esophageal Cancer, Esophagus Cancer, Esophageal Tumor, Esophageal Neoplasm, Esophagus Tumor, Esophagus Neoplasm, Pancreatic Cancer, Pancreatic Tumor, Pancreatic Neoplasms, Head and Neck Cancer, Head and Neck Neoplasms, Head and Neck Tumor, Tumor, Neoplasms, Bladder Cancer, Bladder Neoplasm, Liver Cancer, Liver Neoplasms, Liver Metastases, Oligometastases
Interventions: Radiation therapy; Radiation
Lead sponsor: UMC Utrecht; Other
Eligibility: 18 Years and older
Enrollment: 8,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2030
U.S. locations: 3
States / cities: Pittsburgh, Pennsylvania • Houston, Texas • Milwaukee, Wisconsin

Conditions: Shock, Septic
Interventions: Lactated Ringer, Normal Saline, Plasma-lyte; Drug
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 2 Months to 17 Years
Enrollment: 9,041 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 22
States / cities: Davis, California • Los Angeles, California • San Francisco, California + 19 more

Conditions: Charcot-Marie-Tooth Disease, Type Ia (Disorder), HMSN
Interventions: Not listed
Lead sponsor: University of Iowa; Other
Eligibility: Not listed
Enrollment: 1,050 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2030
U.S. locations: 18
States / cities: Los Angeles, California • Palo Alto, California • Aurora, Colorado + 14 more

Conditions: Breast Cancer, Breast Cancer Recurrent
Interventions: rPBI; Radiation
Lead sponsor: University Health Network, Toronto; Other
Eligibility: 18 Years to 99 Years · Female only
Enrollment: 171 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 3
States / cities: New York, New York • Richmond, Virginia

Conditions: Ascending Aortic Aneurysm Enlargement, Ascending Aorta Aneurysm
Interventions: Thoracic Aortic Surgery; Procedure
Lead sponsor: Ottawa Heart Institute Research Corporation; Other
Eligibility: 18 Years to 79 Years
Enrollment: 610 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2035
U.S. locations: 16
States / cities: San Francisco, California • Iowa City, Iowa • Boston, Massachusetts + 12 more

Conditions: Alcohol Use Disorder
Interventions: High-density transcranial alternating current stimulation, Sham stimulation, Motivational interviewing; Device · Behavioral
Lead sponsor: The Mind Research Network; Other
Eligibility: 21 Years to 60 Years
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Mycobacterium Avium Complex, Nontuberculous Mycobacterium Infection
Interventions: Azithromycin, Ethambutol, Rifampin; Drug
Lead sponsor: Kevin Winthrop; Other
Eligibility: 18 Years and older
Enrollment: 474 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 25
States / cities: Loma Linda, California • San Diego, California • San Francisco, California + 21 more

Conditions: Parkinson's Disease, Depression
Interventions: Repetitive transcranial magnetic stimulation (rTMS); Device
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 21 Years to 85 Years
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 5
States / cities: Los Angeles, California • Gainesville, Florida • Boston, Massachusetts + 2 more

Conditions: Major Depressive Disorder
Interventions: Mecta Spectrum 5000Q paired with Soterix Medical 4X1 HD - ECT Multi-Channel Stimulation Interface; Device
Lead sponsor: University of New Mexico; Other
Eligibility: 50 Years to 80 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Type 2 Diabetes Mellitus
Interventions: Not listed
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 96,759 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Control Network Neuromodulation to Enhance Cognitive Training in Complex Traumatic Brain Injury

The T REX Pilot Study: a Study to Investigate the Use of an Alternative Anaesthetic in Infants.

Vortioxetine Versus Placebo in Major Depressive Disorder Comorbid With Social Anxiety Disorder

Neurobiological Basis of Response to Vayarin in Adults With ADHD: an fMRI Study of Brain Activation Pre and Post Treatment

Cariprazine Versus Placebo for Social Anxiety Disorder

A Study to Compare the Long-term Outcomes After Two Different Anaesthetics

Open-Label Study of Geodon in Non-Rapid Cycling Bipolar II Patients With Major Depression

MEmbranous Nephropathy Trial Of Rituximab

Internet Based Cognitive Behavioral Therapy in Pediatric Chronic Pancreatitis

Vfib by ECG or Echo During Cardiac Arrest

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

A Registry for Patients Treated on the Clinical Trial TAX 3503

Study of Vilazodone to Treat Social Anxiety Disorder

Statins In Intracerbral Hemorrhage

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis

Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2

Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)

Treatment in Thoracic Aortic Aneurysm: Surgery vs Surveillance

A Pilot Study of Non-invasive Brain Stimulation to Boost the Efficacy of Psychotherapy in a Community Sample of People Who Drink Alcohol

Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease

rTMS for Motor and Mood Symptoms of Parkinson's Disease

Electroconvulsive Therapy Amplitude Titration

Impact of Medicaid Health Home on Patients With Diabetes in New York City